Alexion Pharmaceuticals, a subsidiary of AstraZeneca, is a biopharmaceutical company focused on developing and delivering innovative therapies for rare and devastating diseases. The company is dedicated to transforming the lives of people affected by these conditions through continuous research and development.
Focus Areas
Notable Investments
